sealed-air-logo

2011 Annual Report

Financial Highlights

Pro Forma Year Ended December 31, Year Ended December 31,
($ in millions, except per common share data) 2011   2010   20111 2010   2009  
Total Net Sales $ 8,105   $ 7,618   $ 5,641   $ 4,490   $ 4,243  
Percent U.S. 30% 30% 41% 46% 46%
Percent International 70% 70% 59% 54% 54%
U.S. GAAP Operating Profit $ 638   $ 689   $ 447   $ 535   $ 492  
Adjusted Operating Profit* $ 728   $ 749   $ 590   $ 549   $ 509  
Adjusted Operating Profit Margin 9.0% 9.8% 10.5% 12.2% 12.0%
Adjusted EBITDA* $ 1,061   $ 1,122   $ 786   $ 731   $ 707  
As a Percent of Net Sales 13.1% 14.7% 13.9% 16.3% 16.7%
U.S. GAAP Net Earnings—Diluted $ 130   $ 174   $ 148   $ 254   $ 247  
Adjusted Net Earnings—Diluted* $ 184   $ 227   $ 243   $ 281   $ 263  
U.S. GAAP Earnings Per Common Share—Diluted $ 0.62   $ 0.83   $ 0.80   $ 1.44   $ 1.35  
Adjusted Earnings Per Common Share*—Diluted $ 0.88   $ 1.09   $ 1.31   $ 1.60   $ 1.44  
Cash Dividends Paid per Common Share $ 0.52   $ 0.52   $ 0.52   $ 0.50   $ 0.48  
Total Return to Shareholders (Dividends & Share Repurchases) —   —   $ 87   $ 90   $ 76  
Net Cash Provided by Operating Activities —   —   $ 392   $ 483   $ 552  
Capital Expenditures $ 166   $ 137   $ 125   $ 88   $ 80  
Free Cash Flow* —   —   $ 354   $ 388   $ 524  
Net Debt (includes Grace Settlement) —   —   $ 5,156   $ 1,542   $ 1,713  
Return on Total Assets* —   —   —   4.7% 4.7%
Three Year Return on Invested Capital* —   —   9.5% 9.1% 8.9%
Return on Stockholders’ Equity* —   —   —   11.1% 11.8%

12011 results include Diversey results from October 3, 2011 through December 31, 2011.

*Please refer to the following definition and reconciliation pages for reconciliation of non-U.S. GAAP financial measures.

revenue: $8.1 billion1

2011 Pro Forma Revenue Mix Information

North America Latin America EMEA Asia-
Pacific
$2.9B $0.8B $3.0B $1.4B
Food Businesses 48% 47% 26% 35%
Protective Packaging 27% 9% 13% 13%
Diversey 21% 42% 57% 49%
Other2 4% 2% 4% 3%

1Pro forma information reflects legacy Diversey information and is subject to change

2Other includes Specialty Materials, Medical Applications and New Ventures